Renalytix AI PLC Director Dealing (0427L)

TIDMRENX

RNS Number : 0427L

Renalytix AI PLC

19 December 2018

Renalytix AI plc

("RenalytixAI" or the "Company")

Director Dealing

The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 103 pence per share.

Following this purchase, Mr Mills is interested in 9,196,400 Ordinary Shares representing 17.09% of the total voting rights in the Company.

Enquiries:

 
 Renalytix AI plc                                 www.renalytixai.com 
 James McCullough, CEO                            Via Walbrook PR 
                                                   or 
                                                   Tel: [phone] 
                                                   3970 
                                                 -------------------- 
 
 N+1 Singer (Nominated Adviser & Broker)          Tel: [phone] 
                                                 -------------------- 
 Aubrey Powell / James White / George Tzimas 
  (Corporate Finance) 
                                                 -------------------- 
 Tom Salvesen / Mia Gardner (Corporate Broking) 
                                                 -------------------- 
 
 Walbrook PR Limited                              Tel: [phone] 
                                                 -------------------- 
 or [e-mail] 
                                                 -------------------- 
 Paul McManus / Lianne Cawthorne                  Mob: [phone] 
                                                   / 07584 391 303 
                                                 -------------------- 
 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                                    Harwood Capital LLP (Harwood) as 
                                                investment manager to NASCIT 
      --------------------------------------  ------------------------------------------- 
 2     Reason for the notification 
      ----------------------------------------------------------------------------------- 
 a)    Position/status                         Christopher Mills, non-executive 
                                                director of the issuer and director 
                                                of North Altantic Smaller Companies 
                                                Investment Trust plc (NASCIT) 
      --------------------------------------  ------------------------------------------- 
 b)    Initial notification                    Initial notification 
        /Amendment 
      --------------------------------------  ------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ----------------------------------------------------------------------------------- 
 a)    Name                                    Renalytix AI Plc 
      --------------------------------------  ------------------------------------------- 
 b)    LEI                                     213800NTOH3FK3WER551 
      --------------------------------------  ------------------------------------------- 
 4     Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ----------------------------------------------------------------------------------- 
 a)    Description of the                      Ordinary shares of 0.25 pence each 
        financial instrument, 
        type of instrument 
 
       Identification code                     GB00BYWL4Y04 
 
 b)    Nature of the transaction               Purchase of shares 
      --------------------------------------  ------------------------------------------- 
 c)    Price(s) and volume(s) 
                                               --------------------  ------------------ 
                                                Price(s)              Volume(s) 
                                               --------------------  ------------------ 
    103 pence                                                         5,970 
   ----------------------------------------------------------------  ------------------ 
 
 d)    Aggregated information                  N/A 
 
  - Aggregated volume 
 
  - Price 
 
 e)    Date of the transaction                 19 December 2018 
      --------------------------------------  ------------------------------------------- 
 f)    Place of the transaction                London Stock Exchange 
      --------------------------------------  ------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHFKCDBFBDDQBD

(END) Dow Jones Newswires

December 19, 2018 13:28 ET (18:28 GMT)